Health CanadaGeneral Alert
Pradaxa/Pradax (dabigatran etexilate) - New Contraindication in Patients with Ar...
Published: December 21, 2012Recall ID: 48123Category: generalCountry: Canada
Product Description & Identification
Pradaxa/Pradax (dabigatran etexilate) - New Contraindication in Patients with Artificial Heart Valves Requiring Anticoagulant Treatment Due to their Valvular Status - Notice to Hospitals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 48123 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/pradaxapradax-dabigatran-etexilate-new-contraindication-patients-artificial-heart |
| Title | Pradaxa/Pradax (dabigatran etexilate) - New Contraindication in Patients with Artificial Heart Valves Requiring Anticoagulant Treatment Due to their Valvular Status - Notice to Hospitals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2012-12-21 |
| Organization | Marketed health products |